Aayush Sehgal
Aayush Sehgal publishes mostly in Molecular Biology, Physiology and Cellular and Molecular Neuroscience, on topics such as Alzheimer's disease research and treatments, Tryptophan and brain disorders and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #231,698 of 7,710,434 ranked researchers
- Rank in India
- #2,484 of 280,097
- Works
- 135
- Citations
- 5k
- Citations per work
- 36.7
What does Aayush Sehgal research?
Aayush Sehgal's work is mostly in Medicine (22%), Biochemistry, Genetics and Molecular Biology (17%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7555.5%
- Health Sciences3022.3%
- Medicine3022.3%
- Life Sciences3022.2%
- 1Molecular Biology17% of their works
- 2Physiology10% of their works
- 3Cellular and Molecular Neuroscience5% of their works
- 4Pharmacology5% of their works
- 5Endocrinology, Diabetes and Metabolism4% of their works
- 6Neurology4% of their works
Research topics
- Alzheimer's disease research and treatments
- Tryptophan and brain disorders
- Cholinesterase and Neurodegenerative Diseases
- Computational Drug Discovery Methods
- Natural Antidiabetic Agents Studies
- Parkinson's Disease Mechanisms and Treatments
- Mitochondrial Function and Pathology
- Neuroinflammation and Neurodegeneration Mechanisms
Which keywords describe Aayush Sehgal's research?
The keywords of their largest research topics: Oxidative Stress, Neuroinflammation, Neurodegeneration, Amyloid Hypothesis, Tau Pathology, Cytokines, Microglia and Neurodegenerative Diseases.
- Reactive Oxygen Species
- Astrocytes
- Virtual Screening
- Molecular Docking
- Antioxidants
- Depression
- Acetylcholinesterase
- Neurodegenerative Diseases
- Cytokines
- Amyloid Hypothesis
- Neuroinflammation
- Oxidative Stress
- Neurodegeneration
- Tau Pathology
- Microglia
- Mitochondrial Dysfunction
- Cholinesterase Inhibitors
- Tryptophan Metabolism
- Diabetes
- Parkinson's Disease
- a-Synuclein
- Mitochondria
- Synaptic Pruning
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Oxidative Stress565 topics
- Neuroinflammation383 topics
- Neurodegeneration373 topics
- Amyloid Hypothesis221 topic
- Tau Pathology221 topic
- Cytokines162 topics
- Microglia162 topics
- Neurodegenerative Diseases162 topics
- Mitochondrial Dysfunction152 topics
- Acetylcholinesterase101 topic
- Cholinesterase Inhibitors101 topic
- Depression101 topic
- Tryptophan Metabolism101 topic
- Antioxidants91 topic
- Diabetes91 topic
- Molecular Docking91 topic
- Parkinson's Disease91 topic
- Virtual Screening91 topic
- a-Synuclein91 topic
- Astrocytes61 topic
- Mitochondria61 topic
- Reactive Oxygen Species61 topic
- Synaptic Pruning61 topic
Where does Aayush Sehgal work?
Aayush Sehgal's main affiliation in the publication record is Chitkara University, India.
How many publications and citations does Aayush Sehgal have?
OpenAlex counts 135 works and 4,961 citations for Aayush Sehgal, an h-index of 38, ranking #231,698 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Aayush Sehgal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.